Anthony Stein, MD, assessed total marrow and lymphoid irradiation with post-transplant cyclophosphamide in patients with ...

The Brownsboro community came together to hold a birthday parade for a 4-year-old child battling leukemia. Brownsboro native, ...

After years of research into xenotransplantation, the field is at a turning point—yet risks and ethical issues remain ...

Raymond James analyst Ryan Deschner lowered the firm’s price target on Inozyme (INZY) to $12 from $24 and keeps an Outperform rating on the ...

An acute necrotising myopathy is a distinct form of uncommon muscle disease characterised by the rapid advancement of ...

Discover how new global guidelines aim to combat the rising threat of Candida infections with updated treatments and ...

Measles is unlike other childhood viruses. In severe cases, it can cause pneumonia. About 1 in 1,000 patients develops ...

Combining PORT-6 and PORT-7 for a More Comprehensive Immunotherapy Approach ...

An experimental stem cell therapy reversed corneal damage in half of the participants from a recent clinical trial.

There has been little innovation in immunosuppression therapy for organ transplant patients over the past 30 years. The standard of care immunosuppressive drugs used post-transplant have been ...